Avoro Capital Advisors LLC Cerevel Therapeutics Holdings, Inc. Transaction History
Avoro Capital Advisors LLC
- $8.3 Billion
- Q1 2024
A detailed history of Avoro Capital Advisors LLC transactions in Cerevel Therapeutics Holdings, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 7,555,555 shares of CERE stock, worth $309 Million. This represents 3.85% of its overall portfolio holdings.
Number of Shares
7,555,555
Previous 7,555,555
-0.0%
Holding current value
$309 Million
Previous $320 Million
0.31%
% of portfolio
3.85%
Previous 4.57%
Shares
2 transactions
Others Institutions Holding CERE
# of Institutions
227Shares Held
150MCall Options Held
939KPut Options Held
961K-
Bain Capital Investors LLC Boston, MA65.7MShares$2.69 Billion61.94% of portfolio
-
Perceptive Advisors LLC New York, NY10.8MShares$441 Million9.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.46MShares$305 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$223 Million0.01% of portfolio
-
State Street Corp Boston, MA3.53MShares$144 Million0.01% of portfolio
About Cerevel Therapeutics Holdings, Inc.
- Ticker CERE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 155,752,000
- Market Cap $6.37B
- Description
- Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...